Abvc Biopharma ABVC
NASDAQ ABVC
$0.89 -0.01 (-1.11%)
At close: Aug 21, 2026 · 4:00 PM EDT

Abvc Biopharma (ABVC) Property, Plant & Equipment (Net) (2010 - 2026)

Abvc Biopharma (ABVC) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Abvc Biopharma 23.19 Mn 23.19 Mn - 12.83 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 12.83 Mn
Jun 30, 2026 12.83 Mn
Mar 31, 2026 12.82 Mn
Mar 31, 2026 12.82 Mn
Dec 31, 2025 12.84 Mn
Dec 31, 2025 12.84 Mn
Sep 30, 2025 12.85 Mn
Sep 30, 2025 12.85 Mn
Jun 30, 2025 8.22 Mn
Jun 30, 2025 8.22 Mn
Mar 31, 2025 8.17 Mn
Mar 31, 2025 8.17 Mn
Dec 31, 2024 511,088.00
Dec 31, 2024 511,088.00
Sep 30, 2024 531,478.00
Sep 30, 2024 531,478.00
Jun 30, 2024 7.93 Mn
Jun 30, 2024 7.93 Mn
Mar 31, 2024 7.95 Mn
Mar 31, 2024 7.95 Mn